Skip to main content
SpringerLink
Log in

HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  Google Scholar 

  2. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16.

    Article  Google Scholar 

  3. El-Serag HB. Current concepts: hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.

    Article  CAS  Google Scholar 

  4. European Association For The Study Of The Liver, European Organisation For Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.

    Article  Google Scholar 

  5. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.

    Article  CAS  Google Scholar 

  6. Kulik LM, Atassi B, van Holsbeeck L, et al. Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol. 2006;94:572–86.

    Article  CAS  Google Scholar 

  7. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954–60.

    Article  Google Scholar 

  8. Maddala YK, Stadheim L, Andrews JC, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl. 2004;10:449–55.

    Article  Google Scholar 

  9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.

    Article  Google Scholar 

  10. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.

    Article  Google Scholar 

  11. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25–34.

    Article  CAS  Google Scholar 

  12. Sirtex Medical. Package Insert for SIR-Spheres ® microspheres (Yttrium-90 microspheres). http://www.sirtex.com; http://sirtex.com/files/US20Package20Insert1.pdf

  13. MDS Nordion. Package Insert for TheraSphereYttrium-90 glass microspheres. http://www.nordion.com/therasphere/physicians-packageinsert/package-insert-us.pdf

  14. Coldwell D, Sangro B, Wasan H, Salem R, Kennedy A. General selection criteria of patients for radioembolization of liver tumors: an international working group report. Am J Clin Oncol. 2011;34:337–41. doi:10.1097/COC.0b013e3181ec61bb.

    Article  PubMed  Google Scholar 

  15. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13–23. doi:10.1016/j.ijrobp.2006.11.060.

    Article  PubMed  Google Scholar 

  16. Sangro B, Gil-Alzugaray B, Rodriguez J, Sola I, Martinez-Cuesta A, Viudez A, et al. Liver disease induced by radioembolization of liver tumors. Cancer. 2008;112(7):1538–46.

    Article  Google Scholar 

  17. Delbeke D, Martin WH. Positron emission tomography in oncology. Radiol Clin N Am. 2001;39:883–917.

    Article  CAS  Google Scholar 

  18. Sasikumar A, Joy A, Nanabala R, Pillai MRA, Thomas B, Vikraman KR. 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2016;43:795–6.

    Article  Google Scholar 

  19. Soydal C, Alkan A, Ozkan E, Demirkazık A, Kucuk NO. Ga-68 PSMA accumulation in hepatocellular carcinoma. Clin Oncol. 2016;1:1091.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Department, Faculty of Medicine, Çukurova University, Adana, Turkey

    İsa Burak Güney

Authors
  1. İsa Burak Güney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to İsa Burak Güney.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Güney, İ.B. HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT). J Gastrointest Canc 48, 276–280 (2017). https://doi.org/10.1007/s12029-017-9973-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-9973-2

Keywords

Search

Navigation